Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00442169
What this trial is testing

Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults

Who this might be right for
West Nile Fever
Sanofi Pasteur, a Sanofi Company 208
Not applicableUnknownNCT04678024
What this trial is testing

Sensitivity Evaluation of Serological Tests for Covid-19

Who this might be right for
Covid19
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 410
Not applicableWithdrawnNCT02357823
What this trial is testing

Antibodies and Memory Cells Role After Different Pneumococcal Vaccines in HIV Adults

Who this might be right for
HIVPneumococcal Infections
University of Siena
Post-approval studies (Phase 4)Study completedNCT01582698
What this trial is testing

TBE Seropersistence up to 10 Years After First Booster in Adults

Who this might be right for
Tick-borne Encephalitis (TBE)
Pfizer 243
Large-scale testing (Phase 3)Study completedNCT02697474
What this trial is testing

Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.

Who this might be right for
Hepatitis B
Sanofi Pasteur, a Sanofi Company 150
Testing effectiveness (Phase 2)WithdrawnNCT05465876
What this trial is testing

Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLL

Who this might be right for
Chronic Lymphocytic LeukemiaCOVID-19
Sunnybrook Health Sciences Centre
Large-scale testing (Phase 3)Ended earlyNCT05205759
What this trial is testing

Non-inferiority Trial on Monoclonal Antibodies in COVID-19

Who this might be right for
COVID-19
Azienda Ospedaliera Universitaria Integrata Verona 319
Testing effectiveness (Phase 2)Study completedNCT04480424
What this trial is testing

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

Who this might be right for
COVID-19
Grifols Therapeutics LLC 100
Early research (Phase 1)UnknownNCT01937455
What this trial is testing

A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 21
Not applicableStudy completedNCT05313048
What this trial is testing

Prospective Observational Study to Evaluate a Possible Change in APS Antibody Profiles After COVID-19 Infection or Vaccination

Who this might be right for
Antiphospholipid SyndromeCOVID-19 InfectionCOVID-19 Vaccination
Cardioangiologisches Centrum Bethanien 82
Early research (Phase 1)Study completedNCT02840474
What this trial is testing

Phase 1, Open-label, Single Dose Study to Examine Safety, Tolerability, Pharmacokinetics and Virologic Impact of VRC01LS or VRC07-523LS in HIV-infected Viremic Adults

Who this might be right for
HIV-1
National Institute of Allergy and Infectious Diseases (NIAID) 16
Early research (Phase 1)Study completedNCT04223804
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1

Who this might be right for
Human Immunodeficiency Virus (HIV)HIV InfectionHIV-1
AbbVie 41
Not applicableEnded earlyNCT04346589
What this trial is testing

Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients

Who this might be right for
Pneumonia, Ventilator-AssociatedCoronavirus Infection
A.O. Ospedale Papa Giovanni XXIII 9
Not applicableStudy completedNCT02190578
What this trial is testing

Clinical Performance of Reveal G4 Rapid HIV-1 Antibody Test

Who this might be right for
HIV Infections
MedMira Laboratories Inc. 1,649
Not applicableEnrolling By InvitationNCT07833852
What this trial is testing

Long-Term Immune Persistence After Bivalent HPV Vaccination in Females From Study 311-HPV-1005

Who this might be right for
Human Papillomavirus InfectionCervical Intraepithelial Neoplasia
Shanghai Zerun Biotechnology Co.,Ltd 486
Not applicableLooking for participantsNCT07085611
What this trial is testing

Neutralizing Power of Serum Antibodies - 2

Who this might be right for
COVID-19SARS-CoV-2 ViraemiaMonkey Pox+3 more
Centre Hospitalier Régional d'Orléans 30
Early research (Phase 1)Study completedNCT05923424
What this trial is testing

A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults

Who this might be right for
Healthy Volunteers
Regeneron Pharmaceuticals 40
Early research (Phase 1)Study completedNCT00007423
What this trial is testing

Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableLooking for participantsNCT05242159
What this trial is testing

Prevalence and Clinical Significance of Anti-annexin A2 Antibodies in COVID-19 Infection

Who this might be right for
COVID-19
Centre Hospitalier Universitaire, Amiens 300
Testing effectiveness (Phase 2)Looking for participantsNCT05300035
What this trial is testing

Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control

Who this might be right for
HIV/AIDS and Infections
ANRS, Emerging Infectious Diseases 69
Next Page